オーストラリアのオーソバイオロジクス市場動向(~2021)

【英語タイトル】Australia Orthobiologics Market Outlook to 2021

GlobalDataが出版した調査資料(GDMECC1121DB)・商品コード:GDMECC1121DB
・発行会社(調査会社):GlobalData
・発行日:2015年9月11日
・ページ数:45
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:オーストラリア
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥520,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥780,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Australia Orthobiologics Market Outlook to 2021

Summary

GlobalData’s new report, “Australia Orthobiologics Market Outlook to 2021″, provides key market data on the Australia Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments – Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Orthobiologics market categories – Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Orthobiologics market.
- Global corporate-level profiles of key companies operating within the Australia Orthobiologics market.
- Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc. and Stryker Corporation.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Orthobiologics Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Orthobiologics Market, Australia 8
3.1 Orthobiologics Market, Australia, Revenue ($m), 2007-2014 8
3.2 Orthobiologics Market, Australia, Revenue ($m), 2014-2021 10
3.2.1 Bone Grafts and Substitutes Market, Australia, Revenue ($m), by Segment, 2007-2014 12
3.2.2 Bone Grafts and Substitutes Market, Australia, Revenue ($m), by Segment, 2014-2021 14
3.3 Orthobiologics Market, Australia, Volume (Units), 2007-2014 16
3.4 Orthobiologics Market, Australia, Volume (Units), 2014-2021 18
3.4.1 Bone Grafts and Substitutes Market, Australia, Volume (Units), by Segment, 2007-2014 20
3.4.2 Bone Grafts and Substitutes Market, Australia, Volume (Units), by Segment, 2014-2021 22
3.5 Orthobiologics Market, Australia, Average Price ($), 2007-2021 24
3.6 Orthobiologics Market, Australia, Distribution Share by Revenue ($m), 2013-2014 26
3.7 Orthobiologics Market, Australia, Company Share by Revenue ($m), 2014 27
4 Overview of Key Companies in Australia, Orthobiologics Market 29
4.1 Medtronic plc 29
4.1.1 Company Overview 29
4.2 Bioventus LLC 29
4.2.1 Company Overview 29
4.3 DePuy Companies 29
4.3.1 Company Overview 29
4.4 Australian Biotechnologies Pty. Limited 29
4.4.1 Company Overview 29
4.5 Cellumed Co. Ltd. 30
4.5.1 Company Overview 30
4.6 Biomet, Inc. (Inactive) 30
4.6.1 Company Overview 30
4.7 Patterson Medical Holdings, Inc. 30
4.7.1 Company Overview 30
4.8 Seikagaku Corporation 30
4.8.1 Company Overview 30
4.9 Baxter International Inc. 31
4.9.1 Company Overview 31
4.10 Sanofi 31
4.10.1 Company Overview 31
4.11 Stryker Corporation 31
4.11.1 Company Overview 31
4.12 Alphatec Holdings, Inc. 32
4.12.1 Company Overview 32
4.13 Arthrex, Inc. 32
4.13.1 Company Overview 32
5 Orthobiologics Market Pipeline Products 33
6 Appendix 37
6.1 Research Methodology 38
6.1.1 Coverage 38
6.1.2 Secondary Research 38
6.1.3 Primary Research 39
6.1.4 Market Modeling and Forecasting 40
6.1.5 Company Share Analysis 43
6.1.6 Distribution Share Analysis 44
6.2 Expert Panel 45
6.3 GlobalData Consulting 45
6.4 Contact Us 45
6.5 Disclaimer 45

1.1 List of Tables
Table 1: Orthobiologics Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 9
Table 2: Orthobiologics Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Table 3: Bone Grafts and Substitutes Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 13
Table 4: Bone Grafts and Substitutes Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 15
Table 5: Orthobiologics Market, Australia, Volume (Units), Historic, 2007-2014 17
Table 6: Orthobiologics Market, Australia, Volume (Units), Forecast, 2014-2021 19
Table 7: Bone Grafts and Substitutes Market, Australia, Volume (Units), Historic, 2007-2014 21
Table 8: Bone Grafts and Substitutes Market, Australia, Volume (Units), Forecast, 2014-2021 23
Table 9: Orthobiologics Market, Australia, Average Price ($), Historic, 2007-2014 24
Table 10: Orthobiologics Market, Australia, Average Price ($), Forecast, 2014-2021 25
Table 11: Orthobiologics Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 26
Table 12: Orthobiologics Market, Australia, Company Share by Revenue ($m), USD Constant, 2014 28
Table 13: Orthobiologics Market Pipeline Products 33
Table 14: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 40

1.2 List of Figures
Figure 1: Orthobiologics Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 8
Figure 2: Orthobiologics Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 10
Figure 3: Bone Grafts and Substitutes Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 12
Figure 4: Bone Grafts and Substitutes Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 14
Figure 5: Orthobiologics Market, Australia, Volume (Units), Historic, 2007-2014 16
Figure 6: Orthobiologics Market, Australia, Volume (Units), Forecast, 2014-2021 18
Figure 7: Bone Grafts and Substitutes Market, Australia, Volume (Units), Historic, 2007-2014 20
Figure 8: Bone Grafts and Substitutes Market, Australia, Volume (Units), Forecast, 2014-2021 22
Figure 9: Orthobiologics Market, Australia, Company Share (%) 2014 27
Figure 10: GlobalData Epidemiology-Based Forecasting Model 42
Figure 11: GlobalData Capital Equipment-Based Forecasting Model 43
Figure 12: Primary Interviews by Participant Type (%) 44

【掲載企業】

Medtronic plc
Bioventus LLC
DePuy Companies
Australian Biotechnologies Pty. Limited
Cellumed Co. Ltd.
Patterson Medical Holdings, Inc.
Seikagaku Corporation
Baxter International Inc.
Sanofi
Stryker Corporation
Alphatec Holdings, Inc.
Arthrex, Inc.

★調査レポート[オーストラリアのオーソバイオロジクス市場動向(~2021)] (コード:GDMECC1121DB)販売に関する免責事項を必ずご確認ください。
★調査レポート[オーストラリアのオーソバイオロジクス市場動向(~2021)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆